We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

Arrowhead Pharmaceuticals, Inc. shines with 19 clinical programs, strategic partnerships, and promising RNAi data. Click for ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

Johnson & Johnson’s Stelara, Regeneron’s Eylea and Amgen’s Prolia are just some of the drugs facing off against new ...

In a report released today, David Amsellem from Piper Sandler maintained a Buy rating on Amneal Pharmaceuticals (AMRX – Research Report), with ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Akari Therapeutics ( ($AKTX) ) has issued an announcement. On March 14, 2025, Akari Therapeutics announced the appointment of Mr. Abizer ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

At least three new startups have already been launched out of the fund: U.K.-based Forth Therapeutics, French biotech ...

The fund has already screened over 300 projects and made several investments into new companies to catalyze transformative innovation in biotechnology PARIS– (BUSINESS WIRE)– Sofinnova Partners ...

After raising an impressive 1.2 billion euros in 2024, European venture capital firm Sofinnova Partners is topping up its ...